Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Manchester BRC Hearing Health Lead Kevin Munro welcomes the launch of the “Hearing Medicines Discovery Syndicate,”a unique collaboration to accelerate the much-needed development of treatments for hearing loss and tinnitus.
Continue reading full article: Manchester BRC in unique collaboration to accelerate the development of hearing loss treatments
The first global patient has taken part in a clinical trial testing the effectiveness and safety of a new treatment for a rare inflammatory muscle disease. Professor Hector Chinoy is the UK chief investigator of the study and Dr James Lilleker is a sub-investigator. Both are BRC researchers within
Continue reading full article: First global patient takes part in trial of new drug to treat rare inflammatory muscle disease
In the first instalment in our new blog series, Dr Bella Starling, Co-Director of Public Programmes, discusses the benefits translational research can have for society as a whole.
Continue reading full article: How can translational research benefit those who might need it the most?
In his blog clinical pharmacist, Jake Doherty shares how his six-week NIHR Manchester Biomedical Research Centre (BRC) TRACE-COPD study placement has opened his eyes to new possibilities for a research career.
Continue reading full article: From placement to PhD? – A Manchester BRC research placement story
Ellie Badrick summarises the achievements of the top 10 priorities for detecting cancer early project in her latest blog.
Continue reading full article: Top 10 priorities for detecting cancer early – things we learnt during our researchOur researchers are contributing to the largest ever project of its kind, which aims to increase understanding of patient responses to the treatment of seven long-term diseases.
Continue reading full article: BRC researchers contribute to largest ever biomarker project to improve disease management across seven long-term conditions
At home, Dr Philip and Professor Emma Crosbie are just like any other husband and wife juggling the family duties. At work, they are clinical academics who are transforming outcomes for patients with cancer.
Continue reading full article: Feature – The power couple taking on cancer
A ‘life-changing’ potential new drug could be available to lupus patients in the future thanks to ‘breakthrough’ research. The results of the TULIP II study have been published in the New England Journal of Medicine (NEJM), one of the most prestigious, peer-reviewed medical journals in the world.
Continue reading full article: Breakthrough research offers new hope to lupus patients